Literature DB >> 25611311

Phenotype-genotype correlations in hemophilia A carriers are consistent with the binary role of the phase between F8 and X-chromosome inactivation.

C P Radic1, L C Rossetti, M M Abelleyro, T Tetzlaff, M Candela, D Neme, G Sciuccati, M Bonduel, E Medina-Acosta, I B Larripa, M de Tezanos Pinto, C D De Brasi.   

Abstract

BACKGROUND: The recessive X-linked disorder hemophilia A (HA) is rarely expressed in female carriers, most of whom express about half of normal factor VIII activity ( FVIII: C).
OBJECTIVE: To propose an integrative assessment model for the binary role of the phase between the mutated F8 and the active X-chromosome (Xa) in FVIII: C in HA carriers.
METHODS: We studied 67 females at risk of severe HA, comprising five symptomatic females ( FVIII: C < 1.5 IU dL(-1) ) and 14 controls. A correlation study between FVIII: C (observed vs. expected) and X-chromosome inactivation (XCI) patterns (XIPs; androgen receptor gene [AR] system) in blood leukocyte DNA was performed in carriers, by comparison of a model correlating FVIII: C and XIP with arbitrary models devoid of biological significance, and with FVIII: C levels in non-carriers (mean model) as a proxy from background data dispersion not influenced by XIP.
RESULTS: We provide proof-of-concept example from a family presenting with extremely skewed XIPs in which the severe HA phenotype appeared in a heterozygous carrier of a crossover between AR and F8 loci that phased the mutated F8 with the maternally inherited Xa. Furthermore, four cases of severe HA affected women who had a combination of a heterozygous F8 mutation and extremely skewed XIPs in leukocytes or oral mucosa are presented. Correlation analyses between FVIII: C levels and XIPs in carriers (n = 38) but not in non-carriers (n = 20) showed highly significant differences between the proposed correlation model and models without biological significance. The data support a binary influence of XCI, either increasing or decreasing the FVIII: C, subject to the underlying phase set between the F8 mutation and XCI.
CONCLUSIONS: Our evidence suggests that the phase between XCI and mutated F8 acts as a molecular switch conditioning FVIII: C levels and HA expression in carriers.
© 2015 International Society on Thrombosis and Haemostasis.

Entities:  

Keywords:  F8 protein, human; X chromosome; X chromosome inactivation; X-linked genetic diseases; hemophilia A

Mesh:

Substances:

Year:  2015        PMID: 25611311     DOI: 10.1111/jth.12854

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  6 in total

1.  Characterization and genetic diagnosis of centronuclear myopathies in seven Chinese patients.

Authors:  Yan Zhao; Zhe Zhao; Hongrui Shen; Qi Bing; Jing Hu
Journal:  Neurol Sci       Date:  2018-09-19       Impact factor: 3.307

2.  Evaluation of factor VIII polymorphic short tandem repeat markers in linkage analysis for carrier diagnosis of hemophilia A.

Authors:  Sabina Shrestha; Sufang Dong; Zuhua Li; Zhuliang Huang; Fang Zheng
Journal:  Biomed Rep       Date:  2016-07-04

3.  Establishment of a strain of haemophilia-A pigs by xenografting of foetal testicular tissue from neonatally moribund cloned pigs.

Authors:  Hiroyuki Kaneko; Kazuhiro Kikuchi; Michiko Nakai; Daiichiro Fuchimoto; Shunichi Suzuki; Shoichiro Sembon; Junko Noguchi; Akira Onishi
Journal:  Sci Rep       Date:  2017-12-05       Impact factor: 4.379

4.  Application of Indirect Linkage Analysis for Carrier Detection of Hemophilia A in Kurdistan Region of Iraq: Usefulness of Intron 18 BclI T>A, Intron 19 HindIII C>T, and IVS7 nt27 G>A Markers.

Authors:  Aveen M Raouf Abdulqader; Shwan Rachid; Ali Ibrahim Mohammed; Sarwar Noori Mahmood
Journal:  Clin Appl Thromb Hemost       Date:  2019 Jan-Dec       Impact factor: 2.389

5.  X Chromosome inactivation: a modifier of factor VIII and IX plasma levels and bleeding phenotype in Haemophilia carriers.

Authors:  Isabella Garagiola; Mimosa Mortarino; Simona Maria Siboni; Marco Boscarino; Maria Elisa Mancuso; Marina Biganzoli; Elena Santagostino; Flora Peyvandi
Journal:  Eur J Hum Genet       Date:  2020-10-20       Impact factor: 4.246

6.  A new hemophilia carrier nomenclature to define hemophilia in women and girls: Communication from the SSC of the ISTH.

Authors:  Karin P M van Galen; Roseline d'Oiron; Paula James; Rezan Abdul-Kadir; Peter A Kouides; Roshni Kulkarni; Johnny N Mahlangu; Maha Othman; Flora Peyvandi; Dawn Rotellini; Rochelle Winikoff; Robert F Sidonio
Journal:  J Thromb Haemost       Date:  2021-08       Impact factor: 16.036

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.